Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

被引:73
|
作者
Warnecke, Tobias [1 ]
Suttrup, Inga [1 ]
Schroeder, Jens B. [1 ]
Osada, Nani [2 ]
Oelenberg, Stephan [1 ]
Hamacher, Christina [1 ]
Suntrup, Sonja [1 ]
Dziewas, Rainer [1 ]
机构
[1] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[2] Univ Munster, Dept Med Informat, Domagkstr 9, D-48149 Munster, Germany
关键词
Parkinson's disease; Dysphagia; Swallowing; FEES; Levodopa responsiveness; DOPAMINERGIC STIMULATION; SWALLOWING ABNORMALITIES; AGREEMENT; DIAGNOSIS; THERAPY;
D O I
10.1016/j.parkreldis.2016.04.034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: It is still controversially discussed whether central dopaminergic stimulation improves swallowing ability in Parkinson's disease (PD). We evaluated the effect of oral levodopa application on dysphagia in advanced PD patients with motor fluctuations. Methods: In 15 PD patients (mean age 71.93 +/- 8.29 years, mean disease duration 14.33 +/- 5.94 years) with oropharyngeal dysphagia and motor fluctuations endoscopic swallowing evaluation was performed in the off state and on state condition following a specifically developed protocol (FEES-levodopa-test). The respective dysphagia score covered three salient parameters, i.e. premature spillage, penetration/aspiration events and residues, each tested with liquid as well as semisolid and solid food consistencies. An improvement of >30% in this score indicated levodopa responsiveness of dysphagia. Measures were compared between the off-and on-state condition by using the Wilcoxon Test and marginal homogeneity test. Inter- and intrarater reliability was also investigated. Results: Severity of swallowing dysfunction in the off state varied widely. The lowest dysphagia score was 15 points (dysphagia without any aspiration risk). The highest dysphagia score was 84 points (dysphagia with aspiration of all consistencies). Seven patients showed a marked improvement of dysphagia in the on state condition. Eight PD patients did not respond. Inter- and intrarater reliability was excellent for all three subscales in the off state and on state conditions. Conclusions: A significant proportion of advanced PD patients with motor fluctuations and mild to moderate oropharyngeal dysphagia may demonstrate a clinically relevant improvement of swallowing after levodopa challenge. The FEES-levodopa-test is a reliable and sensitive tool to differentiate these responders from non-responders. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 106
页数:7
相关论文
共 50 条
  • [41] Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naive Patients With Parkinson's Disease
    Conti, Valeria
    Izzo, Viviana
    Russillo, Maria Claudia
    Picillo, Marina
    Amboni, Marianna
    Scaglione, Cesa L. M.
    Nicoletti, Alessandra
    Cani, Ilaria
    Cicero, Calogero E.
    De Bellis, Emanuela
    Charlier, Bruno
    Giudice, Valentina
    Somma, Gerardina
    Corbi, Graziamaria
    Barone, Paolo
    Filippelli, Amelia
    Pellecchia, Maria Teresa
    FRONTIERS IN MEDICINE, 2022, 9
  • [42] Levodopa responsiveness in Parkinson’s disease: harnessing real-life experience with machine-learning analysis
    Ruth Djaldetti
    Ben Hadad
    Johnathan Reiner
    Bella Askenazi Kharash
    Boaz Lerner
    Journal of Neural Transmission, 2022, 129 : 1289 - 1297
  • [43] Intonation and Speech Rate in Parkinson's Disease: General and Dynamic Aspects and Responsiveness to Levodopa Admission
    Skodda, Sabine
    Groenheit, Wenke
    Schlegel, Uwe
    JOURNAL OF VOICE, 2011, 25 (04) : E199 - E205
  • [44] Levodopa responsiveness in Parkinson's disease: harnessing real-life experience with machine-learning analysis
    Djaldetti, Ruth
    Hadad, Ben
    Reiner, Johnathan
    Kharash, Bella Askenazi
    Lerner, Boaz
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (10) : 1289 - 1297
  • [45] Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease
    Delea, Thomas E.
    Thomas, Simu K.
    Hagiwara, May
    Mancione, L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1543 - 1552
  • [46] Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson?s disease
    Yan, Jia-Hui
    Ge, Yi-Lun
    Wang, Pu-Zhi
    Li, Wen
    Jin, Hong
    Zhang, Jin-Ru
    Chen, Jing
    Wang, Fen
    Li, Dan
    Mao, Cheng-Jie
    Li, Kai
    Liu, Chun-Feng
    NEUROSCIENCE LETTERS, 2023, 801
  • [47] Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test
    Fabbri, Margherita
    Coelho, Miguel
    Guedes, Leonor Correia
    Chendo, Ines
    Sousa, Catarina
    Rosa, Mario M.
    Abreu, Daisy
    Costa, Nilza
    Godinho, Catarina
    Antonini, Angelo
    Ferreira, Joaquim J.
    PARKINSONISM & RELATED DISORDERS, 2017, 39 : 37 - 43
  • [48] Long Term Response to Levodopa in Parkinson's Disease
    Gupta, Harsh, V
    Lyons, Kelly E.
    Wachter, Nathaniel
    Pahwa, Rajesh
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (03) : 525 - 529
  • [49] Characteristics of levodopa treatment in advanced Parkinson's disease in the experiences of the neurology clinics of Targu Mures, Romania
    Szasz Jozsef Attila
    Szatmari Szabolcs
    Constantin Viorelia
    Mihaly Istvan
    Racz Attila
    Domokos Lajos Csaba
    Vajda Tamas
    Orban-Kis Karoly
    ORVOSI HETILAP, 2019, 160 (17) : 662 - 669
  • [50] The effect of levodopa on vocal function in Parkinson's disease
    Sanabria, J
    Ruiz, PG
    Gutierrez, R
    Marquez, F
    Escobar, P
    Gentil, M
    Cenjor, C
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (02) : 99 - 102